Clinical trial
A Nonrandomized, Non-double Blinded Prospective Cohort Study to Evaluate the Preventive Efficacy of Quadrivalent HPV6/11/16/18 Vaccine for the Persistent Infection of HPV16 Genotype or HPV18 Genotype in Japanese Women Aged 27-45 Years.
NCT04022148 is registered in ClinicalTrials.gov with University of Fukui as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Nonrandomized, Non-double Blinded Prospective Cohort Study to Evaluate the Preventive Efficacy of Quadrivalent HPV6/11/16/18 Vaccine for the Persistent Infection of HPV16 Genotype or HPV18 Genotype in Japanese Women Aged 27-45 Years.
- Lead sponsor
- University of Fukui
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2019
- Completion date
- December 31, 2020
- Enrollment
- 2,800 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of cervix, vaccinia